Publications and Literature

May 11, 2024

A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study to A ssess the Tolerability and Pharmacodynamic Effects of CRD-740, a PDE9 Inhibitor, in Participants with Chronic Heart Failure

The CARDINAL-HF Trial

Oral presentation at the Annual Congress of the Heart Failure Association of the European Society of Cardiology 2024

James Udelson, Jan Bělohlávek, Andrej Dukát, Justin Ezekowitz, Sorel Goland, Bela Merkerly, Eileen O’Meara, Mark Petrie, Piotr Ponikowski, Michele Senni, Mariya Tokmakova, Orly Vardeny, Howard Surks, Scott Solomon, John McMurray